Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Folotyn (pralatrexate)
i
Other names:
PDX, 10-propargyl-10-deazaaminopterin
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Assertio, Aurobindo, CASI, Mundipharma
Drug class:
THF dehydrogenase inhibitor
Related drugs:
‹
pemetrexed (58)
methotrexate (37)
pemetrexed RTD (1)
LX-101 (0)
pemetrexed (0)
methotrexate oral solution (0)
ADX-2191 (0)
methotrexate IV (0)
pemetrexed (58)
methotrexate (37)
pemetrexed RTD (1)
LX-101 (0)
pemetrexed (0)
methotrexate oral solution (0)
ADX-2191 (0)
methotrexate IV (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Peripheral T-cell Lymphoma
No biomarker
Peripheral T-cell Lymphoma
pralatrexate
Sensitive: A1 - Approval
pralatrexate
Sensitive
:
A1
pralatrexate
Sensitive: A1 - Approval
pralatrexate
Sensitive
:
A1
DNMT3B overexpression
T Acute Lymphoblastic Leukemia
DNMT3B overexpression
T Acute Lymphoblastic Leukemia
pralatrexate
Resistant: D – Preclinical
pralatrexate
Resistant
:
D
pralatrexate
Resistant: D – Preclinical
pralatrexate
Resistant
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login